Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingle

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
Immunity|March 24, 2019
A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell ActivationYunyun Yang, Liping Li, Linjie Yuan, et al.
Plos One|February 6, 2013
Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissuesChristopher P Kolbert, Rod M Feddersen, Fariborz Rakhshan, et al.
Cancer Research|December 17, 2008
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot studyVitaly Balan, Pratima Nangia-Makker, Ann G Schwartz, et al.
BMC Medical Genomics|December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platformMonica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trialEdith A Perez, Monica M Reinholz, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
BMC Cancer|October 8, 2014
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerJordan M Reese, Vera J Suman, Malayannan Subramaniam, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
Journal of Internal Medicine|March 4, 2024
The dynamics of B-cell reconstitution post allogeneic hematopoietic stem cell transplantation: A real-world studyGuangyu Zhou, Qian Zhan, Lingle Huang, et al.
Cancers|December 10, 2021
CHFR and Paclitaxel Sensitivity of Ovarian CancerAndrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Immunity|March 24, 2019
A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell ActivationYunyun Yang, Liping Li, Linjie Yuan, et al.
Plos One|February 6, 2013
Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissuesChristopher P Kolbert, Rod M Feddersen, Fariborz Rakhshan, et al.
Cancer Research|December 17, 2008
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot studyVitaly Balan, Pratima Nangia-Makker, Ann G Schwartz, et al.
BMC Medical Genomics|December 22, 2010
Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platformMonica M Reinholz, Jeanette E Eckel-Passow, S Keith Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trialEdith A Perez, Monica M Reinholz, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2013
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831Amylou C Dueck, Monica M Reinholz, Xochiquetzal J Geiger, et al.
BMC Cancer|October 8, 2014
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerJordan M Reese, Vera J Suman, Malayannan Subramaniam, et al.
Breast Cancer Research and Treatment|November 23, 2006
The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenMatthew P Goetz, Stacey K Knox, Vera J Suman, et al.
Journal of Internal Medicine|March 4, 2024
The dynamics of B-cell reconstitution post allogeneic hematopoietic stem cell transplantation: A real-world studyGuangyu Zhou, Qian Zhan, Lingle Huang, et al.
Cancers|December 10, 2021
CHFR and Paclitaxel Sensitivity of Ovarian CancerAndrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, et al.
Pageof 38